2019 Launched Products

Ancavaz Launch:

Zeta launched Ancavaz -is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease, The active components of ANCAVAZ are perindopril arginine and amlodipine besilate, Each ANCAVAZ 5/5 tablet contains 5 mg of perindopril arginine and 5 mg of amlodipine (as besilate ), Each ANCAVAZ 5/10 tablet contains 5 mg of perindopril arginine and 10 mg of amlodipine (as besilate ), Each ANCAVAZ 10/5 tablet contains 10 mg of perindopril arginine and 5 mg of amlodipine (as besilate ), Each ANCAVAZ 10/10 tablet contains 10 mg of perindopril arginine and 10 mg of amlodipine (as besilate )  Pack: 20 coated tab.

Cosmofer Launch:

As part of Zeta Pharma’s endeavor to provide vital medicines to the Egyptian patient, Zeta Pharma has signed the contract as an exclusive agent for the products of the Danish company Pharmacosmos, And re-launched Cosmofer — iron injections for the treatment of iron defiecincy anemia.